Basit öğe kaydını göster

dc.contributor.authorUysal, Nese
dc.contributor.authorBagcivan, Gulcan
dc.contributor.authorToprak, Filiz Unal
dc.contributor.authorSoylu, Yeter
dc.contributor.authorKaya, Bektas
dc.date.accessioned2024-03-12T19:34:35Z
dc.date.available2024-03-12T19:34:35Z
dc.date.issued2021
dc.identifier.issn2459-1459
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.710870
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/480609
dc.identifier.urihttps://hdl.handle.net/20.500.12450/2646
dc.description.abstractObjective: Many cancer survivors have cognitive problems with concentration and memory after cancer treatment. The Attention Function Index (AFI) is a tool developed to evaluate cognitive processes in cancer patients. The purpose of this study was to investigate the adaptation of AFI in Turkish. Methods: This methodological study was conducted with one hundred breast cancer survivors. Data were collected using the information form, AFI, and the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) scale. Internal consistency, test-retest, and item-total scores were analyzed to assess the reliability of the AFI Turkish form. Results: The internal consistency coefficient (Cronbach's alpha) was 0.89 for the Turkish version of AFI. Confirmatory factor analysis for construct validity revealed that the original three-factor structure of AFI was not confirmed, but the two-factor structure of the AFI was confirmed by the fit indices. In the correlation analysis for criterion validity, a statistically significant and positive relationship was found between AFI total scores and EORTC QLQ-C30 total scores. There was a strong positive correlation between test and retest scores (r = 0.524; p<0.01). Conclusions: In this study, it was determined that the two-factor, 10-item version of the AFI, which was evaluated for validity and reliability, was well-matched with the sample in which the scale was administered. The Turkish version of AFI is a valid and reliable tool for breast cancer survivors. The scale tested in cancer survivors and can be used in clinical practice.en_US
dc.language.isoengen_US
dc.publisherMarmara Univ, Inst Health Sciencesen_US
dc.relation.ispartofClinical And Experimental Health Sciencesen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAttention functionen_US
dc.subjectbreast canceren_US
dc.subjectsurvivoren_US
dc.subjectvalidity and reliabilityen_US
dc.titleTurkish Adaptation of Attention Function Index: A Validity and Reliability Studyen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.authoridUnal Toprak, Filiz/0000-0001-8588-7867
dc.authoridBagcivan, Gulcan/0000-0002-9585-6332
dc.identifier.volume11en_US
dc.identifier.issue2en_US
dc.identifier.startpage215en_US
dc.identifier.endpage219en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.trdizinid480609en_US
dc.identifier.doi10.33808/clinexphealthsci.710870
dc.department-temp[Uysal, Nese] Amasya Univ, Fac Hlth Sci, Amasya, Turkey; [Bagcivan, Gulcan] Koc Univ, Sch Nursing, Istanbul, Turkey; [Toprak, Filiz Unal] Abant Izzet Baysal Univ, Fac Hlth Sci, Bolu, Turkey; [Soylu, Yeter; Kaya, Bektas] Ankara Oncol Educ & Training Hosp, Ankara, Turkeyen_US
dc.identifier.wosWOS:000681330400004en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster